Persistence of Detectable Pathogens by Culture-Independent Systems (T2 Magnetic Resonance) in Patients With Bloodstream Infection: Prognostic Role and Possible Clinical Implications

Abstract Background Persistent Staphylococcus aureus bacteremia is associated with metastatic infection and adverse outcomes, whereas gram-negative bacteremia is normally transient and shorter course therapy is increasingly advocated for affected patients. Whether the prolonged detection of pathogen DNA in blood by culture-independent systems could have prognostic value and guide management decisions is unknown. Methods We performed a multicenter, prospective, observational study on 102 patients with bloodstream infection (BSI) to compare time to bloodstream clearance according to T2 magnetic resonance and blood cultures over a 4-day follow-up. We also explored the association between duration of detectable pathogens according to T2 magnetic resonance (magnetic resonance–DNAemia [MR-DNAemia]) and clinical outcomes. Results Time to bloodstream clearance according to T2 magnetic resonance was significantly longer than blood culture clearance (HR, .54; 95% CI, .39–.75) and did not differ according to the causative pathogen (P = .5). Each additional day of MR-DNAemia increased the odds of persistent infection (defined as metastatic infection or delayed source control) both in the overall population (OR, 1.98; 95% CI, 1.45–2.70) and in S. aureus (OR, 1.92; 95% CI, 1.12–3.29) and gram-negative bacteremia (OR, 2.21; 95% CI, 1.35–3.60). MR-DNAemia duration was also associated with no improvement in Sequential Organ Failure Assessment score at day 7 from infection onset (OR, 1.76; 95% CI, 1.21–2.56). Conclusions T2 magnetic resonance may help diagnose BSI in patients on antimicrobials with negative blood cultures as well as to identify patients with metastatic infection, source control failure, or adverse short-term outcome. Future studies may inform its usefulness within the setting of antimicrobial stewardship programs.

[1]  P. Viale,et al.  Impact on clinical outcome of follow-up blood cultures and risk factors for persistent bacteraemia in patients with gram-negative bloodstream infections: a systematic review with meta-analysis. , 2023, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2]  J. Thaden,et al.  Association of Follow-up Blood Cultures With Mortality in Patients With Gram-Negative Bloodstream Infections , 2022, JAMA network open.

[3]  S. Cosgrove,et al.  Optimizing the Management of Uncomplicated Gram-Negative Bloodstream Infections: Consensus Guidance Using a Modified Delphi Process , 2021, Open forum infectious diseases.

[4]  D. Paterson,et al.  Culture independent detection systems for bloodstream infection. , 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[5]  J. Pachón,et al.  Seven versus 14-days course of antibiotics for the treatment of bloodstream infections by Enterobacterales. A randomized, controlled trial. , 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[6]  T. Blauwkamp,et al.  Microbial Cell-Free DNA Identifies Etiology of Bloodstream Infections, Persists Longer Than Conventional Blood Cultures, and its Duration of Detection is Associated with Metastatic Infection in Patients with Staphylococcus aureus and Gram-Negative Bacteremia. , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Mathias W Pletz,et al.  Management of Staphylococcus aureus Bloodstream Infections , 2021, Frontiers in Medicine.

[8]  Á. Soriano,et al.  Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study. , 2020, The Lancet. Infectious diseases.

[9]  A. Gayet-Ageron,et al.  Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial. , 2020, JAMA.

[10]  Paul A. Harris,et al.  The REDCap consortium: Building an international community of software platform partners , 2019, J. Biomed. Informatics.

[11]  J. Perfect,et al.  Performance of the T2Bacteria Panel for Diagnosing Bloodstream Infections , 2019, Annals of Internal Medicine.

[12]  J. Thaden,et al.  Changing Characteristics of Staphylococcus aureus Bacteremia: Results From a 21-Year, Prospective, Longitudinal Study. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  J. Rossen,et al.  Diagnosis of bloodstream infections from positive blood cultures and directly from blood samples: recent developments in molecular approaches. , 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  A. Caliendo,et al.  Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  H. Albrecht,et al.  Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections , 2017, Infection.

[16]  J. Sobel,et al.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  W. Xiong,et al.  Sending repeat cultures: is there a role in the management of bacteremic episodes? (SCRIBE study) , 2015, BMC Infectious Diseases.

[18]  P. Wellman,et al.  T2 Magnetic Resonance Enables Nanoparticle-Mediated Rapid Detection of Candidemia in Whole Blood , 2013, Science Translational Medicine.

[19]  Samuel M. Brown,et al.  A Modified Sequential Organ Failure Assessment Score for Critical Care Triage , 2010, Disaster Medicine and Public Health Preparedness.

[20]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[21]  Mamta Sharma,et al.  Persistence in Staphylococcus aureus bacteremia: Incidence, characteristics of patients and outcome , 2006, Scandinavian journal of infectious diseases.

[22]  C. Woods,et al.  Clinical identifiers of complicated Staphylococcus aureus bacteremia. , 2003, Archives of internal medicine.

[23]  V. Fowler,et al.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.